We reveal that these inhibitors suppress SLC15A4-mediated endolysosomal TLR and NOD features in a variety of human and mouse immune cells; we offer proof of their power to suppress inflammation in vivo As well as in medical settings; and we offer insights into their system of action. Our conclusions https://sybilm419gpw7.sharebyblog.com/profile